Left ventricular energy loss and wall shear stress assessed by vector flow mapping in patients with hypertrophic cardiomyopathy

  • Ling Ji
  • Wenzhi Hu
  • Yonghong Yong
  • Hongping Wu
  • Lei Zhou
  • Di Xu
Original Paper
  • 25 Downloads

Abstract

The aim of this study was to assess left ventricular (LV) summation of energy loss (EL-SUM), average energy loss (EL-AVE) and wall shear stress (WSS) using vector flow mapping (VFM) in patients with hypertrophic cardiomyopathy (HCM). Forty HCM patients, and 40 controls were evaluated by transthoracic echocardiography. Conventional echocardiographic parameters, summation and average of energy loss (EL-total, EL-base, EL-mid and EL-apex), and WSS in each segment were calculated at different phases. Compared with controls, conventional diastolic measurements were impaired in HCM patients. HCM patients also showed increased EL-SUM-total and EL-AVE-total at the peak of LV rapid ejection period as well as decreased EL-SUM-total and EL-AVE-total at the end of early diastole. In controls, EL-SUM and EL-AVE showed a gradual decrease from the basal segment to the apex, this regularity was not observed in HCM patients. Compared with controls, HCM patients showed increased WSS at the peak of the LV rapid ejection period and the atrial contraction period as well as decreased WSS at the end of early diastole (all p < 0.05). WSS was increased slightly at the peak of the LV rapid filling period in HCM patients (p = 0.055). EL and WSS values derived from VFM are novel flow dynamic parameters that can effectively evaluate systolic and diastolic hemodynamic function in HCM patients.

Keywords

Hypertrophic cardiomyopathy Energy loss Wall shear stress Left ventricular Echocardiography Vector flow mapping 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–2779CrossRefGoogle Scholar
  2. 2.
    Fraiche A, Wang A (2016) Hypertrophic cardiomyopathy: new evidence since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline. Curr Cardiol Rep 18:70CrossRefPubMedGoogle Scholar
  3. 3.
    Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124:2761–2796CrossRefPubMedGoogle Scholar
  4. 4.
    Almaas VM, Haugaa KH, Strom EH, Scott H, Smith HJ, Dahl CP, Geiran OR, Endresen K, Aakhus S, Amlie JP, Edvardsen T (2014) Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy. Heart 100:631–638CrossRefPubMedGoogle Scholar
  5. 5.
    Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG (2014) Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 7:11–19CrossRefPubMedGoogle Scholar
  6. 6.
    Wang Y, Hou D, Ma R, Ding G, Yin L, Zhang M (2016) Early detection of left atrial energy loss and mechanics abnormalities in diabetic patients with normal left atrial size: a study combining vector flow mapping and tissue tracking echocardiography. Med Sci Monit 22:958–968CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Rodriguez Munoz D, Markl M, Moya Mur JL, Barker A, Fernandez-Golfin C, Lancellotti P, Zamorano Gomez JL (2013) Intracardiac flow visualization: current status and future directions. Eur Heart J Cardiovasc Imaging 14:1029–1038CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Sengupta PP, Pedrizzetti G, Kilner PJ, Kheradvar A, Ebbers T, Tonti G, Fraser AG, Narula J (2012) Emerging trends in CV flow visualization. JACC Cardiovasc Imaging 5:305–316CrossRefPubMedGoogle Scholar
  9. 9.
    Garcia D, Del Alamo JC, Tanne D, Yotti R, Cortina C, Bertrand E, Antoranz JC, Perez-David E, Rieu R, Fernandez-Aviles F, Bermejo J (2010) Two-dimensional intraventricular flow mapping by digital processing conventional color-Doppler echocardiography images. IEEE Trans Med Imaging 29:1701–1713CrossRefPubMedGoogle Scholar
  10. 10.
    Itatani K, Okada T, Uejima T, Tanaka T, Ono M, Miyaji K, Takenaka K (2013) Intraventricular flow velocity vector visualization based on the continuity equation and measurements of vorticity and wall shear stress. Jpn J Appl Phys 52:7CrossRefGoogle Scholar
  11. 11.
    Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270CrossRefPubMedGoogle Scholar
  12. 12.
    Nogami Y, Ishizu T, Atsumi A, Yamamoto M, Kawamura R, Seo Y, Aonuma K (2013) Abnormal early diastolic intraventricular flow ‘kinetic energy index’ assessed by vector flow mapping in patients with elevated filling pressure. Eur Heart J Cardiovasc Imaging 14:253–260CrossRefPubMedGoogle Scholar
  13. 13.
    Wang Y, Ma R, Ding G, Hou D, Li Z, Yin L, Zhang M (2016) Left ventricular energy loss assessed by vector flow mapping in patients with prediabetes and type 2 diabetes mellitus. Ultrasound Med Biol 42:1730–1740CrossRefPubMedGoogle Scholar
  14. 14.
    Chen M, Jin JM, Zhang Y, Gao Y, Liu SL (2013) Assessment of left ventricular diastolic dysfunction based on the intraventricular velocity difference by vector flow mapping. J Ultrasound Med 32:2063–2071CrossRefPubMedGoogle Scholar
  15. 15.
    Lu J, Li W, Zhong Y, Luo A, Xie S, Yin L (2012) Intuitive visualization and quantification of intraventricular convection in acute ischemic left ventricular failure during early diastole using color Doppler-based echocardiographic vector flow mapping. Int J Cardiovasc Imaging 28:1035–1047CrossRefPubMedGoogle Scholar
  16. 16.
    Rodriguez Munoz D, Moya Mur JL, Fernandez-Golfin C, Becker Filho DC, Gonzalez Gomez A, Fernandez Santos S, Lazaro Rivera C, Rincon Diaz LM, Casas Rojo E, Zamorano Gomez JL (2015) Left ventricular vortices as observed by vector flow mapping: main determinants and their relation to left ventricular filling. Echocardiography 32:96–105CrossRefPubMedGoogle Scholar
  17. 17.
    Zhang H, Liu L, Chen L, Ma N, Zhou L, Liu Y, Li Z, Liu C, Hou R, Zhu S (2013) The evolution of intraventricular vortex during ejection studied by using vector flow mapping. Echocardiography 30:27–36CrossRefPubMedGoogle Scholar
  18. 18.
    Ro R, Halpern D, Sahn DJ, Homel P, Arabadjian M, Lopresto C, Sherrid MV (2014) Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve. J Am Coll Cardiol 64:1984–1995CrossRefPubMedGoogle Scholar
  19. 19.
    Hayashi T, Itatani K, Inuzuka R, Shimizu N, Shindo T, Hirata Y, Miyaji K (2015) Dissipative energy loss within the left ventricle detected by vector flow mapping in children: normal values and effects of age and heart rate. J Cardiol 66:403–410CrossRefPubMedGoogle Scholar
  20. 20.
    Akiyama K, Maeda S, Matsuyama T, Kainuma A, Ishii M, Naito Y, Kinoshita M, Hamaoka S, Kato H, Nakajima Y, Nakamura N, Itatani K, Sawa T (2017) Vector flow mapping analysis of left ventricular energetic performance in healthy adult volunteers. BMC Cardiovasc Disord 17: 21–30CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Li C, Zhang J, Li X, Zhou C, Li H, Tang H, Rao L (2010) Quantification of chronic aortic regurgitation by vector flow mapping: a novel echocardiographic method. Eur J Echocardiogr 11:119–124CrossRefPubMedGoogle Scholar
  22. 22.
    Stugaard M, Koriyama H, Katsuki K, Masuda K, Asanuma T, Takeda Y, Sakata Y, Itatani K, Nakatani S (2015) Energy loss in the left ventricle obtained by vector flow mapping as a new quantitative measure of severity of aortic regurgitation: a combined experimental and clinical study. Eur Heart J Cardiovasc Imaging 16:723–730CrossRefPubMedGoogle Scholar
  23. 23.
    Zhong Y, Liu Y, Wu T, Song H, Chen Z, Zhu W, Cai Y, Zhang W, Bai W, Tang H, Rao L (2016) Assessment of left ventricular dissipative energy loss by vector flow mapping in patients with end-stage renal disease. J Ultrasound Med 35:965–973CrossRefPubMedGoogle Scholar
  24. 24.
    Sengupta PP, Khandheria BK, Korinek J, Jahangir A, Yoshifuku S, Milosevic I, Belohlavek M (2007) Left ventricular isovolumic flow sequence during sinus and paced rhythms: new insights from use of high-resolution Doppler and ultrasonic digital particle imaging velocimetry. J Am Coll Cardiol 49:899–908CrossRefPubMedGoogle Scholar
  25. 25.
    Zhang H, Zhang J, Zhu X, Chen L, Liu L, Duan Y, Yu M, Zhou X, Zhu T, Zhu M, Li H (2012) The left ventricular intracavitary vortex during the isovolumic contraction period as detected by vector flow mapping. Echocardiography 29:579–587CrossRefPubMedGoogle Scholar
  26. 26.
    Lopatin YM, Rosano GM, Fragasso G, Lopaschuk GD, Seferovic PM, Gowdak LH, Vinereanu D, Hamid MA, Jourdain P, Ponikowski P (2016) Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure. Int J Cardiol 203:909–915CrossRefPubMedGoogle Scholar
  27. 27.
    Zhang L, Ding WY, Wang ZH, Tang MX, Wang F, Li Y, Zhong M, Zhang Y, Zhang W (2016) Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy. J Transl Med 14:109CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  • Ling Ji
    • 1
  • Wenzhi Hu
    • 2
  • Yonghong Yong
    • 1
  • Hongping Wu
    • 1
  • Lei Zhou
    • 1
  • Di Xu
    • 1
  1. 1.Department of CardiologyThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
  2. 2.Department of CardiologyThe Second Affiliated Hospital of Nanjing Medical UniversityNanjingChina

Personalised recommendations